Yasmin Lawsuit

November 18, 2010, by Ronald V. Miller, Jr.

There is a great deal of talk about all of the Yaz claims that have been filed but little about Yasmin lawsuits. Fundamentally, the claims are the same. Both Yaz and Yasmin are birth control oral contraceptives. Yasmin has a combination of 3 mg of the progestin, drospirenone, and 0.03 mg of the estrogen, ethinyl estradiol. Yaz is made up of the combination of 3 mg of the progestin, drospirenone, and only .02 mg of the estrogen, ethinyl estradiol.

Yaz and Yasmin are both the same with respect to the critical basis for lawsuits involving Yasmin and Yaz: unlike other birth control pills, both Yaz and Yasmin contain drospirenone.
Other birth control pills work just fine without drospirenone. Yasmin lawsuits allege that drospirenone, a diuretic, adds risks to women that are greater than those posed by other available oral contraceptives. These Yasmin risks include, inter alia heart arrhythmias, myocardial infarction, and other adverse cardiovascular events, including sudden death, transient ischemic attack, embolisms, stroke, and blood clots. Yasmin is also alleged to increase the risk of kidney and gallbladder disease.

  • Drug Recall Lawyer discusses Bayer's latest spin on Yasmin.
  • Story on a woman who filed a Yaz/Yasmin lawsuit.
  • More on the study Bayer is relying upon to defend Yasmin
  • Yaz lawyer: information on Yasmin lawsuits